Resolving Transplant Organ Shortage With Xenotransplantation

EAGAN, Minn.Oct. 8, 2020 /PRNewswire/ — Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts with Makana Therapeutics, a leader in the field of xenotransplantation.

Read Press Release

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.